Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 1265 entries
View as:

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Phase: N/A Priority: Normal
NCT ID: NCT06171386 Org: User:
Start: 04/01/24 End: 04/30/26 Due: 04/30/27

A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT05934851 Org: User:
Start: 11/07/23 End: 03/01/27 Due: 03/01/28

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00068276 Org: User:
Start: 07/31/03 End: 09/30/06 Due: 09/30/07

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone

Phase: N/A Priority: Normal
NCT ID: NCT03529565 Org: User:
Start: 01/31/19 End: 09/18/24 Due: 09/18/25

Patient Centered Simulation For Labor and Delivery

Phase: N/A Priority: Normal
NCT ID: NCT03654079 Org: User:
Start: 07/31/25 End: 05/31/26 Due: 05/31/27

Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT04088630 Org: User:
Start: 08/07/20 End: 06/05/24 Due: 06/05/25

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Phase: N/A Priority: Normal
NCT ID: NCT01719562 Org: User:
Start: 01/01/13 End: 03/08/22 Due: 03/08/23

Consumer Perceptions of Cannabidiol (CBD) Health Claims

Phase: N/A Priority: Normal
NCT ID: NCT06069713 Org: User:
Start: 10/09/23 End: 11/20/23 Due: 11/20/24

Study of Dara-Pembro for Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT04361851 Org: User:
Start: 06/09/21 End: 05/31/27 Due: 05/31/28

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00031798 Org: User:
Start: 04/01/02 End: 05/01/06 Due: 05/01/07

Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT04258410 Org: User:
Start: 09/30/22 End: 01/31/24 Due: 01/31/25

Idiopathic Esophagogastric Junction Outflow Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT04096703 Org: User:
Start: 10/31/21 End: 02/29/24 Due: 02/28/25

High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) to Relieve Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT01971567 Org: User:
Start: 10/31/13 End: 02/06/17 Due: 02/06/18

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02248597 Org: User:
Start: 02/25/15 End: 01/18/23 Due: 01/18/24

Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)

Phase: N/A Priority: Normal
NCT ID: NCT03317925 Org: User:
Start: 07/16/14 End: 04/26/17 Due: 04/26/18

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT00899496 Org: User:
Start: 09/30/05 End: 10/23/09 Due: 10/23/10

Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples

Phase: N/A Priority: Normal
NCT ID: NCT04732767 Org: User:
Start: 01/20/21 End: 06/30/21 Due: 06/30/22

The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.

Phase: N/A Priority: Normal
NCT ID: NCT03097120 Org: User:
Start: 01/31/95 End: 01/31/01 Due: 01/31/02

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01474174 Org: User:
Start: 09/30/11 End: 07/31/12 Due: 07/31/13

Ultrasound Guided Arthrocentesis

Phase: N/A Priority: Normal
NCT ID: NCT00537589 Org: User:
Start: 12/31/04 End: 08/31/06 Due: 08/31/07

Partnerships to Address COVID-19 Inequities

Phase: N/A Priority: Normal
NCT ID: NCT05123729 Org: User:
Start: 04/05/25 End: 09/30/26 Due: 09/30/27

Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)

Phase: N/A Priority: Normal
NCT ID: NCT04155892 Org: User:
Start: 12/04/19 End: 10/31/25 Due: 10/31/26

Topical Treatment for Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06244212 Org: User:
Start: 09/19/24 End: 07/31/26 Due: 07/31/27

Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02473705 Org: User:
Start: 01/31/16 End: 06/30/17 Due: 06/30/18

Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00082940 Org: User:
Start: 08/31/02 End: 06/30/05 Due: 06/30/06